Study of ONO-4578 With and Without ONO-4538 in Subjects Advanced or Metastatic Solid Tumors

Aichi Clinical Site 1, Nagoya

Aichi Clinical Site 2, Toyoake

Chiba Clinical Site 1, Kashiwa

Ehime Clinical Site1, Matsuyama

Gunma Clinical Site 1, Ōta

Hokkaido Clinical Site 1, Sapporo

Iwate Clinical Site 1, Yahaba-cho

Kanagawa Clinical Site 2, Sagamihara

Kanagawa Clinical Site 1, Yokohama

Osaka Clinical Site 2, Hirakata

Osaka Clinical Site 3, Sakai

Osaka Clinical Site 4, Takatsuki

Saitama Clinical Site 2, Hidaka

Saitama Clinical Site 1, Ina-machi

Shizuoka Clinical Site 1, Nagaizumi-Cho

Tokyo Clinical Site 1, Chuo-ku

Tokyo Clinical Site 4, Itabashi-ku

Tokyo Clinical Site 2, Koto-ku

Tokyo Clinical Site 3, Shinjyuku-ku

Fukuoka Clinical Site 1, Fukuoka

Fukuoka Clinical Site 2, Fukuoka

Osaka Clinical Site 1, Osaka